medline.ch Respirationstrakt Neoplasie

	Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives. Mol Cancer Vatankhah A, Hoseinzadeh Moghaddam S, Rahmanian M, Khosropanah S, Oroojalian F, Kesharwani P, Sahebkar A. PMID: 42400029 [PubMed - as supplied by publisher]
	Prognostic significance of nodal subclassification and adjuvant therapy in surgically treated T1-4N1-2M0 non-small cell lung cancer: a single-center retrospective study. BMC Pulm Med Elma B, Ulu, , I. PMID: 42399895 [PubMed - as supplied by publisher]
	Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study. BMC Cancer Agelaki S, Demiri S, Kotsakis A, Mauri D, Mountzios G, Christopoulou A, Christodoulou C, Goumas G, Bafaloukos D, Koumarianou A, Korantzis I, Boukovinas I, Linardou H, Kosmidis P, Zagouri F, Ramfidis V, Emmanouilides C, Desiniotis A, Dimitriadis I, Iliopoulou E, Syrigos KN. PMID: 42399856 [PubMed - as supplied by publisher]
	Clinical outcomes of immune checkpoint inhibitor based therapy in NRG1 fusion positive non small cell lung cancer a retrospective study. Discov Oncol Yan X, Fu X, Long Z, Liu L, Zang Y, Su C. PMID: 42399487 [PubMed - as supplied by publisher]
	Interventional Radiology and Thoracic Oncology: 20 Years of Innovation. J Thorac Oncol Ryan DT, Shah R, Ridge CA. PMID: 42399004 [PubMed - indexed for MEDLINE]
	Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial. Lancet Oncol Brunetti L, Santo V, Pinato DJ, Citarella F, Orlando S, Acker F, Colella V, Ricciuti B, Naidoo J, Nassar A, Wakelee HA, Takada K, Naqash AR, Garassino MC, Greco C, Ramella S, Pantano F, Tonini G, Vincenzi B, Arlunno B, Remon J, Parisi C, Planchard D, Besse B, Desilets A, Routy B, Elkrief A, Barlesi F, Derosa L, Cortellini A. PMID: 42398520 [PubMed - as supplied by publisher]
	Advances in nanocarrier-enabled theranostic strategies for lung cancer diagnosis and management. J Biomater Sci Polym Ed Mehta H, Yadav BKN, Acharya S, Shah BM. PMID: 42398082 [PubMed - as supplied by publisher]
	Peutz-Jeghers Syndrome and lung cancer: does the risk meet the threshold for lung cancer screening? Fam Cancer Shareef F, Konjeti M, Gupta S, Weiss JM. PMID: 42397638 [PubMed - indexed for MEDLINE]
	Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial. Int J Radiat Oncol Biol Phys Mai WX, Huang KZ, Kuo J, Wang E, Wong S, Yauger A, Langer J, Free D, Gebeyehu P, Kathiravan A, Swamy A, Flores KZ, Merrill S, Sianez-Torres D, Kokinos A, Pranoto A, Lao O, Guerrero T, Bedi H, Sala M, Bourhis J, Durham A, Skinner L, Vitzthum LK, Kastelowitz N, Chin A, Diehn M, Loo BW Jr, Blomain ES. PMID: 42397316 [PubMed - as supplied by publisher]
	Correction to "Radiotherapy and Cardiovascular Disease Survival Risk in Non-Small Cell Lung Cancer: A Population-Based Study From the Surveillance, Epidemiology, and End Results Database". Cancer Med PMID: 42397108 [PubMed - in process]
	Research on Predicting the Efficacy of Immunotherapy for Non-small Cell Lung Cancer Based on CT Radiomics and Peripheral Blood Inflammatory Markers. Technol Cancer Res Treat Wen X, Li Y, Hu Y, Chen A, Wang K, Zou W, Xie B, Ma Y. PMID: 42397007 [PubMed - indexed for MEDLINE]
	The Prognostic Significance of Advanced Lung Cancer Inflammation Index in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Using Noninvasive Ventilatory Support. Can Respir J Liu S, Sun W, Zhang L, Wang J. PMID: 42396880 [PubMed - indexed for MEDLINE]
	PDLIM2 acts as a central regulator of ubiquitination, immune signaling, and mitochondrial metabolism in lung cancer suppression (Review). Int J Oncol Chuang TH, Guo JH, Yang JX, Tseng JC, Wang HJ, Lai CY. PMID: 42396651 [PubMed - indexed for MEDLINE]
	Diagnostic performance of machine learning-based radiomics models for predicting epidermal growth factor receptor mutation status in lung adenocarcinoma in Chinese patients: A systematic review and meta-analysis. J Int Med Res Yang J, Jiang J, Peng J, Li J, Mi P, Chen G. PMID: 42396618 [PubMed - indexed for MEDLINE]
	Integration of lung tissue proteomics and genome-wide association data to identify lung cancer susceptibility proteins and potential drug targets. medRxiv Xu S, Shi J, Shu XO, Tao R, Dou Y, Guo X, Wen W, Yang Y, Zhang B, Wu J, Deppen SA, Li B, Zheng W, Long J, Cai Q. PMID: 42396338 [PubMed]
	Circadian rhythms and lung cancer biology and immunotherapy: Emerging opportunities and challenges. Chin Med J Pulm Crit Care Med Tian F, Wang S, Huang Z, Ruan Z, Dai J, Yan H, Huang J, Yang D, Li X, Zeng L, Xu Q, Zhang Y. PMID: 42396194 [PubMed]
	Molecular mechanisms and therapeutic targets in lung cancer-nerve crosstalk. Chin Med J Pulm Crit Care Med Xu Z, Huang S, Chu Q. PMID: 42396193 [PubMed]
	The role of statins in the treatment of lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors: a protocol for systematic review and meta-analysis. Front Med (Lausanne) Yuan S, Li B, Jiang Y, Shen L, Fu Z, Liu L. PMID: 42396142 [PubMed]
	Who is more likely to receive up-to-date lung cancer screening? Identifying key barriers using principal component analysis and SHAP modeling: a weighted cross-sectional analysis of the 2024 BRFSS. Front Public Health Li S, He J, Li F, Jin C, Tian H. PMID: 42395284 [PubMed - indexed for MEDLINE]
	Sinonasal and skull base phosphaturic mesenchymal tumours: a case series and narrative review. Front Endocrinol (Lausanne) Pei G, Lin R, Li G, Lai Y. PMID: 42395188 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 161212

Seite 1 von 8061



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung